Information:
Fel:
ID
34168
Beskrivning
Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion; ODM derived from: https://clinicaltrials.gov/show/NCT01256801
Länk
https://clinicaltrials.gov/show/NCT01256801
Nyckelord
Versioner (1)
- 2019-01-14 2019-01-14 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
14 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Breast Neoplasms NCT01256801
Eligibility Breast Neoplasms NCT01256801
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasms NCT01256801
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
patients should be histologically confirmed with metastatic breast cancer and malignant pleural effusion
boolean
ID.2
Item
an eastern cooperative oncology group (ecog) performance status of 0-2;
boolean
ID.3
Item
at least one measurable lesion;
boolean
ID.4
Item
normal cardiac, hepatic, renal and bone marrow functions;
boolean
ID.5
Item
life expectancy ≥3 months;
boolean
ID.6
Item
discontinuity of previous chemotherapy for a minimum of 4 weeks.
boolean
ID.7
Item
not receive chemotherapy in pleural cavity
boolean
ID.8
Item
previous history of other malignancies;
boolean
ID.9
Item
previous surgery history on the needle biopsy organ;
boolean
ID.10
Item
serious or uncontrolled concurrent medical illness.
boolean